comparemela.com

Latest Breaking News On - Remdesivir - Page 7 : comparemela.com

An extremely rare case report of rebound multi-system inflammatory syndrome in children

Researchers described the case report of an infant boy experiencing rebound MIS-C.

Research squareAmerican college of rheumatologyAmerican collegeCovid 19Kawasaki diseaseArs cov 2Evere acute respiratoryEvere acute respiratory syndrome

"How was notice even issued in this": Supreme Court junks plea against use of Remdesivir, Favipiravir for COVID treatment

The Supreme Court on Monday dismissed a plea alleging that two medicines - Remdesivir and Favipiravir - were being used for treatment of COVID-19 without approval.

Justice jb pardiwalaJustice dy chandrachudCentral bureau of investigationChief justiceCentral bureauCosmetics actSupreme courtSupreme court of indiaCji dy chandrachudJustice ps narasimhaCovid 19Covid pandemicAdvocate ml sharmaPharmacetical firmsDrugs and cosmectics actCovid 19 treatment

Study finds that current antiviral drugs retain efficacy against newly emerged Omicron subvariants

Researchers assessed the efficacy of antiviral medications against novel Omicron subvariants.

South koreaRepublic of koreaShidlovski shutterstockGlobal initiative on sharing avian influenza dataCytometry industry focusGlobal initiativeSharing avian influenza dataCoronavirus disease covid 19Amino acidPublic healthArs cov 2Evere acute respiratoryEvere acute respiratory syndrome

The decision-making process for the launch of trials for COVID-19 repurposed antivirals

Researchers reviewed the decision-making process for performing randomized clinical trials for three drugs under consideration for repurposing for COVID-19 treatment: remdesivir, molnupiravir, and tenofovir disoproxil fumarate.

Internal medicineDrug repurposingObservational studiesDiscovery industry focusCoronavirus disease covid 19Covid 19Drug repurposingClinical trialN vitroPublic healthArs cov 2Evere acute respiratoryEvere acute respiratory syndrome

Remdesivir 100mg price: Ministry directed not to further liaise with HC in BD

ISLAMABAD: The government has directed Ministry of National Health Services, Regulations and Coordination not to.

Drug regulatory authority of pakistanPakistan high commission dhakaBangladesh high commissionMinistry of national health servicesPakistan high commissionNational health servicesDrug actDrug regulatory authorityCommercial secretaryDeputy high commissionerBeximo pharmaceutical bangladeshPolicy boardDrug pricing policyBusiness recorderRemdesivir 100mg price

vimarsana © 2020. All Rights Reserved.